ANOVA PANCAN result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:11
iorio@ebi.ac.uk


Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer


Individual drug analysis: 222


Drug details and screening numbers

Drug Name: BX-912
Drug ID: 222
Synonyms: KIN001-175
Brand name:
Target: PDPK1 (PDK1)

Number of cell lines screened: 924
Screening concentration range(s): 0.04 to 10.24 uM


Statistically significant associations identified = 3
association id
FEATURE
Drug id
Propr
Public
Drug Name
Drug Target
N FEATURE pos
N FEATURE neg
log max Conc tested
FEATURE neg logIC50 MEAN
FEATURE pos logIC50 MEAN
FEATURE deltaMEAN IC50
FEATURE IC50 effectSize
FEATURE neg Glass delta
FEATURE pos Glass delta
ANOVA FEATURE pval
Tissue ANOVA pval
MSI ANOVA pval
ANOVA FEATURE FDR %
a291
EWSR1-FLI1_mut
222
1
1
BX-912
PDPK1 (PDK1)
16
905
2.33
2.78
0.793
-1.99
1.1 *
1.1 *
1.3 *
2.17e-04
4e-62
3.73e-01
12
a518
XRN1_mut
222
1
1
BX-912
PDPK1 (PDK1)
15
906
2.33
2.77
1.39
-1.38
0.77 .
0.77 .
0.61 .
7.75e-04
5.83e-62
3.74e-01
25
a526
MLL2_mut
222
1
1
BX-912
PDPK1 (PDK1)
97
824
2.33
2.83
2.06
-0.768
0.43
0.43
0.43
7.9e-04
5.87e-62
3.74e-01
25


All-tests volcano plot